Trade-Ideas LLC identified

Hologic

(

HOLX

) as a post-market leader candidate. In addition to specific proprietary factors, Trade-Ideas identified Hologic as such a stock due to the following factors:

  • HOLX has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $86.7 million.
  • HOLX is up 2.2% today from today's close.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in HOLX with the Ticky from Trade-Ideas. See the FREE profile for HOLX NOW at Trade-Ideas

More details on HOLX:

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. HOLX has a PE ratio of 52. Currently there are 9 analysts that rate Hologic a buy, no analysts rate it a sell, and 7 rate it a hold.

The average volume for Hologic has been 3.0 million shares per day over the past 30 days. Hologic has a market cap of $10.2 billion and is part of the health care sector and health services industry. The stock has a beta of 0.70 and a short float of 4% with 4.00 days to cover. Shares are down 4.8% year-to-date as of the close of trading on Tuesday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

TheStreetRatings.com

Analysis:

TheStreet Quant Ratings

rates Hologic as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, impressive record of earnings per share growth, expanding profit margins, compelling growth in net income and notable return on equity. We feel its strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated.

Highlights from the ratings report include:

  • HOLX's revenue growth has slightly outpaced the industry average of 5.7%. Since the same quarter one year prior, revenues slightly increased by 5.8%. This growth in revenue appears to have trickled down to the company's bottom line, improving the earnings per share.
  • HOLOGIC INC has improved earnings per share by 41.2% in the most recent quarter compared to the same quarter a year ago. The company has demonstrated a pattern of positive earnings per share growth over the past two years. We feel that this trend should continue. During the past fiscal year, HOLOGIC INC increased its bottom line by earning $0.46 versus $0.06 in the prior year. This year, the market expects an improvement in earnings ($1.91 versus $0.46).
  • The gross profit margin for HOLOGIC INC is rather high; currently it is at 67.82%. It has increased from the same quarter the previous year. Regardless of the strong results of the gross profit margin, the net profit margin of 9.93% trails the industry average.
  • The return on equity has improved slightly when compared to the same quarter one year prior. This can be construed as a modest strength in the organization. When compared to other companies in the Health Care Equipment & Supplies industry and the overall market, HOLOGIC INC's return on equity is below that of both the industry average and the S&P 500.
  • The company, on the basis of net income growth from the same quarter one year ago, has significantly underperformed compared to the Health Care Equipment & Supplies industry average, but is greater than that of the S&P 500. The net income increased by 43.8% when compared to the same quarter one year prior, rising from $47.90 million to $68.90 million.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.